Free Trial

Atlantic Coastal Acquisition Corp. II (ACABW) Competitors

$0.03 0.00 (0.00%)
As of 07/23/2025

ACABW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, BFRIW, BTMDW, BCTXW, CALA, and CELUW

Should you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Atlantic Coastal Acquisition Corp. II vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Atlantic Coastal Acquisition Corp. II. 180 Life Sciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

180 Life Sciences beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACABW vs. The Competition

MetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$474.69M$6.44B$9.49B
Dividend YieldN/A5.35%4.19%4.00%
P/E RatioN/A0.8014.1219.95
Price / SalesN/A655.651,789.0382.68
Price / CashN/A178.73128.7058.45
Price / BookN/A3.411.965.82
Net IncomeN/A-$141.08M$1.24B$258.42M
7 Day PerformanceN/A0.72%0.75%1.94%
1 Month PerformanceN/A3.35%3.83%12.02%
1 Year PerformanceN/A50.20%23.78%20.80%

Atlantic Coastal Acquisition Corp. II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.0015
ATNFW
180 Life Sciences
N/A$0.01
-12.4%
N/A+12.5%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.18
+5.9%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.65
+7.1%
N/A-31.3%$0.00$585.60M0.004Gap Down
BFRIW
Biofrontera
N/A$0.10
+2.9%
N/A+170.5%$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
-1.5%
N/AN/A$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.04
+12.5%
N/A-59.3%$0.00N/A0.008Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.2%$0.00N/A0.0060
CELUW
Celularity
N/A$0.05
flat
N/A+197.0%$0.00$54.22M0.00220Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:ACABW) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners